Development and application of a validated gradient elution HPLC method for simultaneous determination of 5-fluorouracil and paclitaxel in dissolution samples of 5-fluorouracil/paclitaxel-co-eluting stents

Journal of Pharmaceutical and Biomedical Analysis

Volumn 59, Issue 1, 2012, Pages 179-183

  Chen, Weiluan ^a   Shen, Yuanyuan ^a   Rong, Haojun ^a   Lei, Lei ^a   Guo, Shengrong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Drug eluting stent; HPLC; Paclitaxel; Simultaneous determination

Indexed keywords

FLUOROURACIL; METHANOL; PACLITAXEL;

AQUEOUS SOLUTION; ARTICLE; DRUG ELUTING STENT; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG-ELUTING STENTS; FLUOROURACIL; LIMIT OF DETECTION; LINEAR MODELS; PACLITAXEL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SOLUTIONS;

EID: 82255192161     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.10.005     Document Type: Article

References (18)

1. Ilson D.H., Ajani J., Bhalla K., Forastiere A., Huang Y., Patel P., Martin L., Donegan J., Pazdur R., Reed C., Kelsen D.P. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J. Clin. Oncol. 1998, 16:1826-1834.
2. Gupta R.S. Cross-resistance of Vinblastine- and Taxol-resistant Mutants of Chinese Hamster Ovary Cells to Other Anticancer Drugs 1985, US Department of Health, Education and Welfare, Silver Spring, MD, ETATS-UNIS.
3. Kim Y.H., Shin S.W., Kim B.S., Kim J.H., Kim J.G., Mok Y.J., Kim C.S., Rhyu H.S., Hyun J.H., Kim J.S. Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer 1999, 85:295-301.
4. Meluch A.A., Hainsworth J.D., Gray J.R., Thomas M., Whitworth P.L., Davis J.L., Greco F.A. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network Phase II Trial. Cancer J. 1999, 5:84-91.
5. Goyal N., El Achchabi A., Goldberg E., Hochhaus G. Simultaneous determination of dexamethasone, dexamethasone 21-acetate, and paclitaxel in a simulated biological matrix by RP-HPLC: assay development and validation. J. Liq. Chromatogr. Relat. Technol. 2008, 31:1478-1491.
6. Monsuez J.J., Charniot J.C., Vignat N., Artigou J.Y. Cardiac side-effects of cancer chemotherapy. Int. J. Cardiol. 2010, 144:3-15.
7. Lei L., Liu X., Guo S., Tang M., Cheng L., Tian L. 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors. J. Control. Release 2010, 146:45-53.
8. Liu X., Lei L., Hou J.W., Tang M.F., Guo S.R., Wang Z.M., Chen K.M. Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application. J. Mater. Sci.-Mater. M. 2011, 22:327-337.
9. Gupte A., Ciftci K. Formulation and characterization of paclitaxel, 5-FU and paclitaxel+5-FU microspheres. Int. J. Pharm. 2004, 276:93-106.
10. Liu K., Zhong D., Zou H., Chen X. Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:550-556.
11. Pisano R., Breda M., Grassi S., James C.A. Hydrophilic interaction liquid chromatography-APCI-mass spectrometry determination of 5-fluorouracil in plasma and tissues. J. Pharm. Biomed. Anal. 2005, 38:738-745.
12. Fahmy O.T., Korany M.A., Maher H.M. High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma. J. Pharm. Biomed. Anal. 2004, 34:1099-1107.
13. Basileo G., Breda M., Fonte G., Pisano R., James C.A. Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry. J. Pharm. Biomed. Anal. 2003, 32:591-600.
14. ®) in biological samples with application to preclinical pharmacokinetics and biodistribution. J. Pharm. Biomed. Anal. 2005, 39:170-176.
15. Alcântara A.M.P.d.P., Vitor R.V., Vieira E.P., Martins I. Simultaneous detection of three antineoplastic drugs on gloves by liquid chromatography with diode array detector. Braz. J. Pharm. Sci. 2010, 46:731-740.
16. Larson R.R., Khazaeli M.B., Dillon H.K. A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents. Appl. Occup. Environ. Hyg. 2003, 18:120-131.
17. Larson R.R., Khazaeli M.B., Dillon H.K. Development of an HPLC method for simultaneous analysis of five antineoplastic agents. Appl. Occup. Environ. Hyg. 2003, 18:109-119.
18. T.U.S., Pharmacopeia, The United State Pharmacopeia (2007).